Every Day, 17 People Die Waiting For An Organ.
we can change that.
75% of donor organs are too damaged for transplant.
It only takes $17 to make sure everyone who needs an organ gets one.
Beauty With Purpose
At the heart of Sweet Chemistry is the science of Xylyx Bio, our parent company and co-founder, whose team of biomedical engineers, surgeons, physicians, and scientists is dedicated to eliminating the organ donor waitlist through organ bioengineering.
Brilliant scientists, it turns out, don't always have a PR team. So we became theirs.
Xylyx Bio is turning discarded donor organs into transplantable ones. Every time you engage with Sweet Chemistry, you're helping shine a light on that work. And if you're able to go one step further, your donation to their GoFundMe directly funds it.
As featured in forbes
"People in the beauty industry often joke that they aren't saving lives, but in the case of Sweet Chemistry, they actually are."
Every Day, 17 People Die Waiting For An Organ
Xylyx Bio's goal is to change that by growing the pool of donor organs that can be safely transplanted.
Rather than trying to build organs from scratch, their approach is to fix up the thousands of organs that are being thrown away. A lot of donor organs just go to the morgue with the equivalent of bruises. Xylyx creates the conditions that enable them to rehabilitate those organs.
Help Fund The First Human Trials
Last year, Xylyx Bio lost a $900,000 NIH grant when federal funding for medical research was cut. Every day without funding is another day the human trials are delayed — and another day 17 people die waiting.
It takes as little as $17 to be part of changing that. Your donation puts you at the forefront of a breakthrough that could make the organ transplant waitlist obsolete.
The Science That Could End the Waitlist
Xylyx Bio is a regenerative medicine company whose technology, derived from extracellular matrix peptides, regenerates damaged donor organs. Over 10 years of research alongside collaborators at Columbia University and Vanderbilt Medical Center has brought this work through preclinical stages and to the threshold of human trials. This means a lung that once would have been discarded can now go to someone who needs it.
The science exists. The only thing standing between Xylyx and the first human trial is funding. If you're able to contribute, you will be playing a role in saving lives that really don't need to be lost.
As recognized by
Press
New York Times, 2020
Injured and unusable lungs were restored with respirators and pig blood. The procedure one day may increase the supply of organs for transplant.
press
Forbes, 2026
The science behind Sweet Chemistry provides the technology for impressively efficacious anti-aging skincare products—and the potential to save thousands of lives by healing organs.
The Waitlist Isn't A Statistic To Everyone
For Dr. John O'Neill, This work has never been abstract
“I saw firsthand the impact that this had. It went from ‘I hope to just live another couple of months to see my oldest son graduate high school’ to see his youngest daughter graduate nursing school, and he met his grandkids. What has motivated me and driven me through most of my life is the impact that this kind of work can have.”
--
Dr. John O'Neill, Chief Scientific Officer & Co-Founder, Xylyx Bio